Aspirin and Cancer Prevention and Treatment: Are We There Yet? | Citedby Results | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Aspirin and Cancer Prevention and Treatment: Are We There Yet?

Cancer Epidemiol Biomarkers Prev (2012) 21 (9): 1439–1440.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial

David B. Liesenfeld
Akke Botma
Nina Habermann
Reka Toth
Christoph Weigel
Odilia Popanda
Karel D. Klika
John D. Potter
Johanna W. Lampe
Cornelia M. Ulrich

Cancer Epidemiology, Biomarkers & Prevention (2016) 25 (1): 180.

Prevention and Treatment of Cancer With Aspirin: Where Do We Stand?

Boris Pasche
Minghui Wang
Michael Pennison
Hugo Jimenez

Seminars in Oncology (2014) 41 (3): 397.

Treatment of cytomegalovirus infections beyond acute disease to improve human health

Cecilia Söderberg-Nauclér

Expert Review of Anti-infective Therapy (2014) 12 (2): 211.

Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: Colon cancer family registry

Dominique Scherer
Lisel M. Koepl
Elizabeth M. Poole
Yesilda Balavarca
Liren Xiao
John A. Baron
Li Hsu
Anna E. Coghill
Peter T. Campbell
Sarah E. Kleinstein
Jane C. Figueiredo
Johanna W. Lampe
Katharina Buck
John D. Potter
Richard J. Kulmacz
Mark A. Jenkins
John L. Hopper
Aung K. Win
Polly A. Newcomb
Cornelia M. Ulrich
Karen W. Makar

Genes, Chromosomes and Cancer (2014) 53 (7): 568.

Pancreas Cancer Meets the Thunder God

Sunil R. Hingorani
John D. Potter

Science Translational Medicine (2012) 4 (156)